IDIBELL (Institut d'investigació biomédica de Bellvitge)http://www.idibell.cat/es-caIDIBELLCayetano González: Using Drosophila tumours to understand malignant growth ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/614/cayetano-gonzalez-using-drosophila-tumours-to-understand-malignant-growth2018-04-23Presentació del Pla director urbanístic Granvia-Llobregat ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/613/presentacio-del-pla-director-urbanistic-granvia-llobregat2018-04-23[off-program] Stefano Pluchino: Signaling Properties of Stem Cells and their Cargo Vesicles ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/612/off-program-stefano-pluchino-signaling-properties-of-stem-cells-and-their-cargo-vesicles2018-04-20[OFF-PROGRAM] Alejandra Bruna: A biobank of breast cancer explants with preserved intra-tumour heterogeneity and its future directions ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/611/off-program-alejandra-bruna-a-biobank-of-breast-cancer-explants-with-preserved-intra-tumour-heterogeneity-and-its-future-directions2018-04-23[Thesis] Jorge Gómez: Identification of mechanisms of acquired resistance to taxanes in triple-negative breast cancer using patient-derived xenografts ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/610/thesis-jorge-gomez-identification-of-mechanisms-of-acquired-resistance-to-taxanes-in-triple-negative-breast-cancer-using-patient-derived-xenografts2018-04-19ACCIONES INDIVIDUALES MARIE SKLODOWSKA - CURIE H2020 - CONVOCATORIA 2018 ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/609/acciones-individuales-marie-sklodowska-curie-h2020-convocatoria-20182018-04-23[Off-program] James McKay: Genetic susceptibility of lung cancer, lessons learned from a very large genome wide association study ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/608/off-program-james-mckay-genetic-susceptibility-of-lung-cancer-lessons-learned-from-a-very-large-genome-wide-association-study2018-04-17[Research in Progress] Pilar Mur: BRF1 Mutations in Hereditary Colon Cancer ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/607/research-in-progress-pilar-mur-brf1-mutations-in-hereditary-colon-cancer2018-04-16Accelerator Meeting Point at IDIBELL ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/606/accelerator-meeting-point-at-idibell2018-04-11[Research in Progress] Pere Llinàs: SVIP Methylation Contributes to Metabolic Shift in HNC cells ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/605/research-in-progress-pere-llinas-svip-methylation-contributes-to-metabolic-shift-in-hnc-cells2018-04-09Achieving project success: stakeholders & risk management ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/604/achieving-project-success-stakeholders-risk-management2018-04-03IDIBELL Scientific Retreat 2018 ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/603/idibell-scientific-retreat-20182018-03-26[Research in Progress] Caroline Mauvezin: Novel function of lysosomes in mitosis for cancer therapy ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/602/research-in-progress-caroline-mauvezin-novel-function-of-lysosomes-in-mitosis-for-cancer-therapy2018-03-26BUSQUES UN DOCTORAT? DOCTORATS INDUSTRIALS ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/601/busques-un-doctorat-doctorats-industrials2018-03-26José I. López: Old challenges and new solutions unveiling intratumor heterogeneity ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/600/jose-i-lopez-old-challenges-and-new-solutions-unveiling-intratumor-heterogeneity2018-03-19Alberto Pereda: Electrical synapses and their interactions with chemical synapses ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/599/alberto-pereda-electrical-synapses-and-their-interactions-with-chemical-synapses2018-03-15IV curso de manejo multidisciplinar sobre el diagnóstico y tratamiento del melanoma ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/598/iv-curso-de-manejo-multidisciplinar-sobre-el-diagnostico-y-tratamiento-del-melanoma2018-03-12[Research in Progress] Meritxell Pons: Role of astrocytes on neuroinflammatory mechanisms of Parkinson's disease ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/597/research-in-progress-meritxell-pons-role-of-astrocytes-on-neuroinflammatory-mechanisms-of-parkinsons-disease2018-03-12[Research in Progress] Marta Sánchez Delgado: The polymorphic imprinting in the human placenta ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/596/research-in-progress-marta-sanchez-delgado-the-polymorphic-imprinting-in-the-human-placenta2018-02-26III IDIBELL PhD day ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/595/iii-idibell-phd-day2018-03-15[Research in Progress] Eduard Cabré Estivill: Targeting Uveal Melanoma Cells Responsible for Metastasis ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/594/research-in-progress-eduard-cabre-estivill-targeting-uveal-melanoma-cells-responsible-for-metastasis2018-02-19[Research in Progress] George Rastis: Understanding the tumor supressor activity of SIRT6 the role of the epigenetic factors SUV39H1 and G9A in it ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/593/research-in-progress-george-rastis-understanding-the-tumor-supressor-activity-of-sirt6-the-role-of-the-epigenetic-factors-suv39h1-and-g9a-in-it2018-02-19Acte homenatge Dr. Eduardo Jaurrieta ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/592/acte-homenatge-dr-eduardo-jaurrieta2018-02-16Xerrada amb Erwin Neher, premi Nobel de Medicina

El guanyador del premi Nobel de Medicina de 1991 coneixerà l’IDIBELL i els seus investigadors més joves el proper dimecres 21 de febrer

]]>
http://www.idibell.cat/modul/actes-i-sessions/ca/591/xerrada-amb-erwin-neher-premi-nobel-de-medicina2018-02-16
[IDIBELL TALKS] Victor Küppers: Vivir con entusiasmo ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/590/idibell-talks-victor-kuppers-vivir-con-entusiasmo2018-02-13Tecnologia per a la medicina del futur ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/589/tecnologia-per-a-la-medicina-del-futur2018-02-07Sessió informativa AES 2018 ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/588/sessio-informativa-aes-20182018-02-01[OFF-PROGRAM] Susana Puig: Genètica i immunologia en melanoma. Implicacions terapèutiques ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/587/off-program-susana-puig-genetica-i-immunologia-en-melanoma-implicacions-terapeutiques2018-01-29[THESIS] Daniel Caballero: New experimental approaches to study the relevance of the TGF-beta and EGF receptor during liver tumorigenesis ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/586/thesis-daniel-caballero-new-experimental-approaches-to-study-the-relevance-of-the-tgf-beta-and-egf-receptor-during-liver-tumorigenesis2018-01-26Giorgio Seano: In vivo dynamics and targeting of vessel co-option and mechanical stress in brain tumors ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/585/giorgio-seano-in-vivo-dynamics-and-targeting-of-vessel-co-option-and-mechanical-stress-in-brain-tumors2018-01-26Presentació del projecte de foment de la qualitat docent al campus Bellvitge ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/584/presentacio-del-projecte-de-foment-de-la-qualitat-docent-al-campus-bellvitge2018-01-261r sLHam de Dones Científiques ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/583/1r-slham-de-dones-cientifiques2018-01-26[TECHNICAL SEMINAR] Analysis of Molecular Interactions analysis by Surface Plasmon Resonance ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/582/technical-seminar-analysis-of-molecular-interactions-analysis-by-surface-plasmon-resonance2018-01-26[Research in progress] Eugènia Almacellas Canal: Role of lysosomes in cell division ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/581/research-in-progress-eugenia-almacellas-canal-role-of-lysosomes-in-cell-division2018-01-23Jornada de presentació del Centre de Medicina Regenerativa de Barcelona (CMR[B]) ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/580/jornada-de-presentacio-del-centre-de-medicina-regenerativa-de-barcelona-cmrb2018-01-18Lindibell, recerca amb swing! ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/579/lindibell-recerca-amb-swing2018-01-26Christopher Mueller: From embryo to adult: new insights into the function of RANKL in immunity ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/578/christopher-mueller-from-embryo-to-adult-new-insights-into-the-function-of-rankl-in-immunity2018-01-17Mohamed Bentires-Alj: ''Breast tumor heterogeneity, resistance and metastasis'' ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/576/mohamed-bentires-alj-breast-tumor-heterogeneity-resistance-and-metastasis2018-02-16Astrid Müller: New perspectives in behavioral addictions ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/575/astrid-muller-new-perspectives-in-behavioral-addictions2018-01-03Marc Suñé Pou: Cationic solid lipid nanoparticles (SLNs): promising drug delivery systems ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/574/marc-sune-pou-cationic-solid-lipid-nanoparticles-slns-promising-drug-delivery-systems2018-01-03[Research in Progress] N.Simonet:SirT7 is an auto-ADP-ribosyltransferase that regulates Polycomb function upon stress through histone var. macroH2A1.1 ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/573/research-in-progress-nsimonetsirt7-is-an-auto-adp-ribosyltransferase-that-regulates-polycomb-function-upon-stress-through-histone-var-macroh2a112018-01-03[Research in Progress] Iratxe Zuazo: Anti-tumor effects of Semaphorin 4D blockade unravel a novel pro-invasive mechanism of vascular targeting agents ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/572/research-in-progress-iratxe-zuazo-anti-tumor-effects-of-semaphorin-4d-blockade-unravel-a-novel-pro-invasive-mechanism-of-vascular-targeting-agents2018-01-17[Research in Progress] C. Tebé: The association between type 2 diabetes mellitus, hip fracture, and post-hip-fracture mortality: a multi-state cohort ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/571/research-in-progress-c-tebe-the-association-between-type-2-diabetes-mellitus-hip-fracture-and-post-hip-fracture-mortality-a-multi-state-cohort2018-01-03[Research in Progress] Cristina Oliveira Mateos: Epigenetic regulation mediated by antisense non-coding RNAs and its impact on oncogenic pathways ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/570/research-in-progress-cristina-oliveira-mateos-epigenetic-regulation-mediated-by-antisense-non-coding-rnas-and-its-impact-on-oncogenic-pathways2018-01-03Lliurament dels premis del comitè de recerca a la millor publicació científica i a la millor tesi doctoral del 2016 ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/569/lliurament-dels-premis-del-comite-de-recerca-a-la-millor-publicacio-cientifica-i-a-la-millor-tesi-doctoral-del-20162017-12-18Informe del director ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/568/informe-del-director2017-11-24Off-program seminar. Eva Rodriguez Aznar: Signaling pathways at the crossroad between survival, proliferation and differentiation ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/567/off-program-seminar-eva-rodriguez-aznar-signaling-pathways-at-the-crossroad-between-survival-proliferation-and-differentiation2017-11-23CMR[B] Lecture Series. Maria Carolina Florian: “Aging of hematopoietic stem cells and the epigenetic drift: a pathway to rejuvenation” ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/566/cmrb-lecture-series-maria-carolina-florian-aging-of-hematopoietic-stem-cells-and-the-epigenetic-drift-a-pathway-to-rejuvenation2017-11-23Recerca i Salut, som a prop teu: Diabetis ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/565/recerca-i-salut-som-a-prop-teu-diabetis2017-11-20Amino Acid Transport defects ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/564/amino-acid-transport-defects2017-11-13INTRODUCING CMR[B]: An official presentation for IDIBELL researchers ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/563/introducing-cmrb-an-official-presentation-for-idibell-researchers2017-11-13Álvaro Martínez del Pozo: The metamorphosis driving a water-soluble protein into the membrane

El divendres 17 de novembre de 2017 a les 13h tindrà lloc el seminari “The metamorphosis driving a water-soluble protein into the membrane” a càrrec de Álvaro Martínez del Pozo, PhD (Departamento de Bioquímica y Biología Molecular, UCM). Convidat pel Dr. Carles Solsona i Dr. Joan Blasi.

]]>
http://www.idibell.cat/modul/actes-i-sessions/ca/562/lvaro-martinez-del-pozo-the-metamorphosis-driving-a-water-soluble-protein-into-the-membrane2017-11-13
Festa MOVEMBER al Debut! ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/561/festa-movember-al-debut2017-10-27[Research in Progress] Adrià Bernat Peguera: Targeting EGFR as a therapy for human skin SCC ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/560/research-in-progress-adria-bernat-peguera-targeting-egfr-as-a-therapy-for-human-skin-scc2017-11-23[Research in Progress] Guillermo Yoldi: RANK signaling: an important player in the tumor and immune system crosstalk ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/559/research-in-progress-guillermo-yoldi-rank-signaling-an-important-player-in-the-tumor-and-immune-system-crosstalk2017-10-18Open Access Week at IDIBELL: iMarina presentation & workshops ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/558/open-access-week-at-idibell-imarina-presentation-workshops2017-10-18Xavier Trepat: Tumour invasion by stromal forces ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/557/xavier-trepat-tumour-invasion-by-stromal-forces2017-10-16Ángel Guerrero: Genomic profiling of ER-positive breast cancer after neoadjuvant endocrine therapy ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/556/ngel-guerrero-genomic-profiling-of-er-positive-breast-cancer-after-neoadjuvant-endocrine-therapy2017-10-04Luis Arnes: Positionally-conserved lncRNAs are necessary for the terminal differentiation of pancreatic lineages in development and disease ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/555/luis-arnes-positionally-conserved-lncrnas-are-necessary-for-the-terminal-differentiation-of-pancreatic-lineages-in-development-and-disease2017-09-28TERTULIAS ONCOLÓGICAS DEL CONGRESO EUROPEO ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/554/tertulias-oncolgicas-del-congreso-europeo2017-09-26[Thesis] Miguel Ángel Santos: Clinicopathologic correlations and neuroimaging biomarkers in primary progressive aphasia ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/553/thesis-miguel-ngel-santos-clinicopathologic-correlations-and-neuroimaging-biomarkers-in-primary-progressive-aphasia2017-09-26[PhD] Joanna Sierpowska:Functional mapping of language pathways in the brain: a combined intraoperative electrical stimulation & neuroimaging approach ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/552/phd-joanna-sierpowskafunctional-mapping-of-language-pathways-in-the-brain-a-combined-intraoperative-electrical-stimulation-neuroimaging-approach2017-09-22Steven Katz: Germline genetic testing and counseling after diagnosis of breast cancer

Seminar hosted by Victor Moreno, PhD

]]>
http://www.idibell.cat/modul/actes-i-sessions/ca/551/steven-katz-germline-genetic-testing-and-counseling-after-diagnosis-of-breast-cancer2017-09-21
[THESIS] Abduljalil Farwati: “Potencial diagnóstico de los miRNAs en patología inflamatoria vascular (preeclampsia e ictus)” ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/550/thesis-abduljalil-farwati-potencial-diagnostico-de-los-mirnas-en-patologia-inflamatoria-vascular-preeclampsia-e-ictus2017-09-20Francesc Garcia Gonzalo: Ciliary Functions of Phosphoinositides

El divendres 15 de desembre de 2017 a les 13h, a Sala Pau Viladiu de l'ICO (Hospital Duran i Reynals) tindrà lloc el seminari “Ciliary Functions of Phosphoinositides” a càrrec de Francesc Garcia Gonzalo, PhD (Instituto de Investigaciones Biomédicas Alberto Sols (CSIC-UAM) & Departamento de Bioquímica, Universidad Autónoma de Madrid &

Instituto de Investigación del Hospital Universitario de La Paz (IdiPAZ)). Convidat per José Luis Rosa, PhD.

]]>
http://www.idibell.cat/modul/actes-i-sessions/ca/549/francesc-garcia-gonzalo-ciliary-functions-of-phosphoinositides2017-10-31
Debat en dessensibilització a quimioteràpics ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/548/debat-en-dessensibilitzacio-a-quimioterapics2017-09-19Synaptic metabolism and brain circuitries in IEM ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/547/synaptic-metabolism-and-brain-circuitries-in-iem2017-09-14[Thesis] Ferran Riaño Canalias: The effect of inhibition of nucleotide synthesis on ribosome biogenesis and the induction of p53 ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/546/thesis-ferran-riano-canalias-the-effect-of-inhibition-of-nucleotide-synthesis-on-ribosome-biogenesis-and-the-induction-of-p532017-09-14[Thesis] Carmen Morcelle: The role of the RPL5/RPL11/5S rRNA complex in mediating p53 levels in response to c-Myc depletion in colorectal carcinoma ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/545/thesis-carmen-morcelle-the-role-of-the-rpl5rpl115s-rrna-complex-in-mediating-p53-levels-in-response-to-c-myc-depletion-in-colorectal-carcinoma2017-09-14[Research in Progress] Humberto Ferreira: Epigenetic regulation of non-coding regions in cancer ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/544/research-in-progress-humberto-ferreira-epigenetic-regulation-of-non-coding-regions-in-cancer2017-09-14[Thesis] Silvia García Monclús: EPHA2 com a diana terapèutica pel sarcoma d'Ewing ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/543/thesis-silvia-garcia-monclus-epha2-com-a-diana-terapeutica-pel-sarcoma-dewing2017-09-06[Research in Progress] Francisco David Morón: c-Myc effects in translation: mTORC1 signaling, protein synthesis and ribosome biogenesis ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/542/research-in-progress-francisco-david-moron-c-myc-effects-in-translation-mtorc1-signaling-protein-synthesis-and-ribosome-biogenesis2017-09-05[Research in Progress] Santiago Rello: BH3-mimetics as reinforcers of Dinaciclib therapy for Soft-tissues sarcoma ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/541/research-in-progress-santiago-rello-bh3-mimetics-as-reinforcers-of-dinaciclib-therapy-for-soft-tissues-sarcoma2017-09-05[Research in Progress] Santiago Rello: BH3-mimetics as reinforcers of Dinaciclib therapy for Soft-tissues sarcoma ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/541/research-in-progress-santiago-rello-bh3-mimetics-as-reinforcers-of-dinaciclib-therapy-for-soft-tissues-sarcoma2017-09-05[Research in Progress] Ananda Marina Rodilla: Anticancer effects of novel anion transporter molecules in lung cancer ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/540/research-in-progress-ananda-marina-rodilla-anticancer-effects-of-novel-anion-transporter-molecules-in-lung-cancer2017-09-05[Research in Progress] Olga Almacellas: Insights into the oncogenic role of lysyl oxidase-like 2 in rhabdomyosarcoma ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/539/research-in-progress-olga-almacellas-insights-into-the-oncogenic-role-of-lysyl-oxidase-like-2-in-rhabdomyosarcoma2017-09-05[Research in Progress] Olga Almacellas: Insights into the oncogenic role of lysyl oxidase-like 2 in rhabdomyosarcoma ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/539/research-in-progress-olga-almacellas-insights-into-the-oncogenic-role-of-lysyl-oxidase-like-2-in-rhabdomyosarcoma2017-09-05[Research in Progress] Montserrat Pérez: Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/538/research-in-progress-montserrat-perez-bromodomain-inhibition-shows-antitumoral-activity-in-mice-and-human-luminal-breast-cancer2017-09-05[Research in Progress] Montserrat Pérez: Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/538/research-in-progress-montserrat-perez-bromodomain-inhibition-shows-antitumoral-activity-in-mice-and-human-luminal-breast-cancer2017-09-05[Research in Progress] Montserrat Pérez: Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/538/research-in-progress-montserrat-perez-bromodomain-inhibition-shows-antitumoral-activity-in-mice-and-human-luminal-breast-cancer2017-09-05[Research in Progress] Montserrat Pérez: Bromodomain inhibition shows antitumoral activity in mice and human luminal breast cancer ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/538/research-in-progress-montserrat-perez-bromodomain-inhibition-shows-antitumoral-activity-in-mice-and-human-luminal-breast-cancer2017-09-05[Research in Progress] María Henar Alonso: Implementación de metodología estadística en la detección del mosaicismo genético ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/537/research-in-progress-maria-henar-alonso-implementacion-de-metodologia-estadistica-en-la-deteccion-del-mosaicismo-genetico2017-09-05[Research in Progress] María Henar Alonso: Implementación de metodología estadística en la detección del mosaicismo genético ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/537/research-in-progress-maria-henar-alonso-implementacion-de-metodologia-estadistica-en-la-deteccion-del-mosaicismo-genetico2017-09-05[Research in Progress] María Henar Alonso: Implementación de metodología estadística en la detección del mosaicismo genético ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/537/research-in-progress-maria-henar-alonso-implementacion-de-metodologia-estadistica-en-la-deteccion-del-mosaicismo-genetico2017-09-05[Research in Progress] María Henar Alonso: Implementación de metodología estadística en la detección del mosaicismo genético ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/537/research-in-progress-maria-henar-alonso-implementacion-de-metodologia-estadistica-en-la-deteccion-del-mosaicismo-genetico2017-09-05[Research in Progress] María Henar Alonso: Implementación de metodología estadística en la detección del mosaicismo genético ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/537/research-in-progress-maria-henar-alonso-implementacion-de-metodologia-estadistica-en-la-deteccion-del-mosaicismo-genetico2017-09-05[Research in Progress] Valentín Navarro: Inferencia Bayesiana vs frecuentista vs decisión: un punto de vista crítico sobre p-valores ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/535/research-in-progress-valentin-navarro-inferencia-bayesiana-vs-frecuentista-vs-decision-un-punto-de-vista-critico-sobre-p-valores2017-09-05Ana M. Plana: Nature and role of immune cells in the brain after stroke ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/534/ana-m-plana-nature-and-role-of-immune-cells-in-the-brain-after-stroke2017-10-02[Research in Progress] Roser E. Pons-Cusarch: Mechanisms of malignization after anti-VEGF therapies in Renal Cell Carcinoma ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/533/research-in-progress-roser-e-pons-cusarch-mechanisms-of-malignization-after-anti-vegf-therapies-in-renal-cell-carcinoma2017-09-05[PhD] Mayelín Domínguez González: Daño oxidativo y regulación redox en el envejecimiento cerebral: vulnerabilidad regional ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/532/phd-mayelin-dominguez-gonzalez-dano-oxidativo-y-regulacion-redox-en-el-envejecimiento-cerebral-vulnerabilidad-regional2017-09-01David J. Kwiatkowski: Genetic and epigenetic dissection of angiomyolipoma and lymphangioleiomyomatosis - understanding mechanism

El dimarts 12 de setembre de 2017 a les 8h, a Sala Pau Viladiu de l'ICO (Hospital Duran i Reynals) tindrà lloc el seminari “Genetic and epigenetic dissection of angiomyolipoma and lymphangioleiomyomatosis - understanding mechanism” a càrrec de David J. Kwiatkowski, MD PhD (Medical Oncologist, Thoracic Oncology Program, Dana-Farber Cancer Institute Institute. Harvard Medical School). Convidat per Miquel Àngel Pujana, PhD.

 

]]>
http://www.idibell.cat/modul/actes-i-sessions/ca/531/david-j-kwiatkowski-genetic-and-epigenetic-dissection-of-angiomyolipoma-and-lymphangioleiomyomatosis-understanding-mechanism2017-09-01
Jeff Rual: The tumor suppressor L3MBTL3 is a novel modulator of Notch signaling

El divendres 29 de setembre de 2017 a les 13h, a Sala Pau Viladiu de l'ICO (Hospital Duran i Reynals) tindrà lloc el seminari “The tumor suppressor L3MBTL3 is a novel modulator of Notch signaling” a càrrec de Jeff Rual, PhD (Universitat de Michigan). Convidat per Julián Cerón, PhD.

]]>
http://www.idibell.cat/modul/actes-i-sessions/ca/530/jeff-rual-the-tumor-suppressor-l3mbtl3-is-a-novel-modulator-of-notch-signaling2017-09-01
Sinisa Volarevic: The interplay between impaired ribosome biogenesis and p53

El dijous 28 de setembre de 2017 a les 13h, a Sala Pau Viladiu de l'ICO (Hospital Duran i Reynals) tindrà lloc el seminari The interplay between impaired ribosome biogenesis and p53” a càrrec de Sinisa Volarevic, PhD (Department de Medicina Molecular i Biotecnologia, Facultat de Medicina, Universitat de Rijeka). Convidat per Sara Kozma, PhD.

]]>
http://www.idibell.cat/modul/actes-i-sessions/ca/528/sinisa-volarevic-the-interplay-between-impaired-ribosome-biogenesis-and-p532017-09-01
Acte entrega donació Club Land Rover ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/527/acte-entrega-donacio-club-land-rover2017-07-25EATRIS Translational Medicine Conference 2017: enhancing predictivity ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/526/eatris-translational-medicine-conference-2017-enhancing-predictivity2017-07-19H2020: Oportunitats en H2020 SC1 2018-20 ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/525/h2020-oportunitats-en-h2020-sc1-2018-202017-09-18Curs de reumatologia per a residents ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/524/curs-de-reumatologia-per-a-residents2017-07-04NeuroSpring 2017 - A journey through Parkinson’s disease ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/523/neurospring-2017-a-journey-through-parkinsons-disease2017-06-07IDIBELL Seminars. Marta Valle: Applications of Population Pharmacokinetic Modeling and Simulation ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/522/idibell-seminars-marta-valle-applications-of-population-pharmacokinetic-modeling-and-simulation2017-04-28EUROPEAN RESEARCH COUNCIL (ERC) - 10 anys de recerca d'excel·lència ]]>http://www.idibell.cat/modul/actes-i-sessions/ca/521/european-research-council-erc-10-anys-de-recerca-dexcellencia2017-04-21